Cell Therapeutics Inc. (CTIC) Posts Surprise Q4 Profit of 8c/Share
Tweet Send to a Friend
Cell Therapeutics Inc. (NASDAQ: CTIC) reported Q4 EPS of $0.08 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
